Poliovirus (PV) VLPs Vaccine

clicks:4571
Product Category: HUMAN VACCINE分类
product description:　　Poliomyelitis is a disease caused by Poliovirus (PV). It is an acute intestinal infectious disease mainly reflecting in limb paralysis and affecting children under five years old. As a worldwide and extremely harmful acute infectious disease, poliomyelitis doesn’t have specific treatment. Poliomyelitis can be divided into three serum types including type I, II and III without cross immunity among them. In view of the current prevention of poliomyelitis, SCUVI takes advantage of BEVS and solves the key problem of the VLPs expression and assembly. SCUVI obtain the strains which have efficient VLPs expression including PV type I, II and III, and verify the satisfactory immunogenicity of the VLPs.

[→] Human Papilloma Virus (HPV) Vaccine

Product Details

【->】Human Respiratory Syncytial Virus (RSV) Vaccine Human Papilloma Virus (HPV) Vaccine EV71 Whole Virus Vaccine Poliovirus (PV) VLPs Vaccine EV71 VLPs Vaccine

HUMAN VACCINE

POSITION：HOME> PRODUCT> HUMAN VACCINE> HUMAN VACCINE分类>Poliovirus...

PRODUCTS

Friendly Link

广州安捷生物医学技术有限公司
广州呼吸疾病研究所

Yipinhong Pharmacy Limited co.,Ltd

Contact us

Add:2nd Floor, Building C6, Science and Technology Enterprise Accelerator, Guangzhou Development Zone, No. 11, Kaiyuan Avenue, Guangzhou, China
Tel：020-89856010
Code：510663
Fax：020-89856019

HOME

ABOUT

R&D

PRODUCT

NEWS

JOIN US

HUMAN VACCINE

VETERINARY VACCINE

PILOT SERVICE

ANTIGEN CUSTOMIZATION

CELL CULTURE